Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7,227,333
-
Total 13F shares
-
18,491,349
-
Share change
-
+9,313,789
-
Total reported value
-
$80,617,885
-
Price per share
-
$4.36
-
Number of holders
-
58
-
Value change
-
+$40,696,600
-
Number of buys
-
40
-
Number of sells
-
20
Institutional Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q1 2020
As of 31 Mar 2020,
Kezar Life Sciences Inc - COMMON-STOCK (KZR) was held by
58 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,491,349 shares.
The largest 10 holders included
Bellevue Group AG, FMR LLC, FRANKLIN RESOURCES INC, BlackRock Inc., BVF INC/IL, VICTORY CAPITAL MANAGEMENT INC, VANGUARD GROUP INC, CITADEL ADVISORS LLC, CHI Advisors LLC, and STATE STREET CORP.
This page lists
58
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.